Allarity Therapeutics
ALLR
11 hedge funds and large institutions have $1.63M invested in Allarity Therapeutics in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.
728% more capital invested
Capital invested by funds: $197K → $1.63M (+$1.44M)
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
10% more funds holding
Funds holding: 10 → 11 (+1)
5.77% more ownership
Funds ownership: 1.29% → 7.07% (+5.8%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$350K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$310K |
| 3 |
State Street
Boston,
Massachusetts
|
+$173K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$127K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$118K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$51.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$48.5K |
| 3 |
Jane Street
New York
|
-$26.6K |
| 4 |
Squarepoint
New York
|
-$14.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.1K |
ALLR Hedge Fund Activity: Q3 2025 in Review
11 institutional investors reported a position in Allarity Therapeutics (ALLR) for Q3 2025, worth a combined $1.63M — up 728% from $197K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ALLR positions and 6 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Private Advisor Group, opening a new position worth an estimated $350K. The largest seller was XTX Topco, exiting entirely with an estimated $51.5K sold.
- 11 institutional investors held Allarity Therapeutics (ALLR) as of Q3 2025, up from 10 in Q2 2025.
- Funds reported $1.63M of Allarity Therapeutics stock for Q3 2025, up 728% quarter-over-quarter.
- 7 funds opened new Allarity Therapeutics positions in Q3 2025 and 6 closed out, a net change of +1 holder.
- The largest Allarity Therapeutics buyer in Q3 2025 was Private Advisor Group, an estimated $350K added.
- The largest Allarity Therapeutics seller in Q3 2025 was XTX Topco, an estimated $51.5K sold.
Based on aggregated 13F filings for Q3 2025.